These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Inhaled mometasone furoate reduces oral prednisone usage and improves lung function in severe persistent asthma. Karpel JP; Nayak A; Lumry W; Craig TJ; Kerwin E; Fish JE; Lutsky B Respir Med; 2007 Mar; 101(3):628-37. PubMed ID: 16875813 [TBL] [Abstract][Full Text] [Related]
5. [Effect of 1-year specific immunotherapy with standardized house dust mite vaccine on mild to moderate allergic asthmatic patients]. Wang HY; Lin XP; Hao CL; Zhang CQ; Sun BQ; Zheng JP; Chen P; Sheng JY; Wu A; Zhong NS Zhonghua Jie He He Hu Xi Za Zhi; 2006 Oct; 29(10):679-87. PubMed ID: 17129496 [TBL] [Abstract][Full Text] [Related]
6. A randomized, double-blind, placebo-controlled study of the CRTH2 antagonist OC000459 in moderate persistent asthma. Barnes N; Pavord I; Chuchalin A; Bell J; Hunter M; Lewis T; Parker D; Payton M; Collins LP; Pettipher R; Steiner J; Perkins CM Clin Exp Allergy; 2012 Jan; 42(1):38-48. PubMed ID: 21762224 [TBL] [Abstract][Full Text] [Related]
7. Budesonide turbuhaler delivered once daily improves health-related quality of life in adult patients with non-steroid-dependent asthma. Banov C; Howland WC; Lumry WR; Parasuraman B; Uryniak T; Liljas B Allergy Asthma Proc; 2003; 24(2):129-36. PubMed ID: 12776447 [TBL] [Abstract][Full Text] [Related]
8. Inhaled mometasone furoate reduces oral prednisone requirements while improving respiratory function and health-related quality of life in patients with severe persistent asthma. Fish JE; Karpel JP; Craig TJ; Bensch GW; Noonan M; Webb DR; Silverman B; Schenkel EJ; Rooklin AR; Ramsdell JW; Nathan R; Leflein JG; Grossman J; Graft DF; Gower RG; Garay SM; Frigas E; Degraff AC; Bronsky EA; Bernstein DI; Berger W; Shneyer L; Nolop KB; Harrison JE J Allergy Clin Immunol; 2000 Nov; 106(5):852-60. PubMed ID: 11080706 [TBL] [Abstract][Full Text] [Related]
9. Comparison of roflumilast, an oral anti-inflammatory, with beclomethasone dipropionate in the treatment of persistent asthma. Bousquet J; Aubier M; Sastre J; Izquierdo JL; Adler LM; Hofbauer P; Rost KD; Harnest U; Kroemer B; Albrecht A; Bredenbröker D Allergy; 2006 Jan; 61(1):72-8. PubMed ID: 16364159 [TBL] [Abstract][Full Text] [Related]
10. Effectiveness of omalizumab in patients with inadequately controlled severe persistent allergic asthma: an open-label study. Niven R; Chung KF; Panahloo Z; Blogg M; Ayre G Respir Med; 2008 Oct; 102(10):1371-8. PubMed ID: 18657960 [TBL] [Abstract][Full Text] [Related]
12. Ciclesonide reduces the need for oral steroid use in adult patients with severe, persistent asthma. Bateman E; Karpel J; Casale T; Wenzel S; Banerji D Chest; 2006 May; 129(5):1176-87. PubMed ID: 16685007 [TBL] [Abstract][Full Text] [Related]
13. Suitability of forced expiratory volume in 1 second/forced vital capacity vs percentage of predicted forced expiratory volume in 1 second for the classification of asthma severity in adolescents. van Dalen C; Harding E; Parkin J; Cheng S; Pearce N; Douwes J Arch Pediatr Adolesc Med; 2008 Dec; 162(12):1169-74. PubMed ID: 19047545 [TBL] [Abstract][Full Text] [Related]
14. Inhaled lidocaine for the treatment of asthma: lack of efficacy in two double-blind, randomized, placebo-controlled clinical studies. Abuan T; Yeager M; Montgomery AB J Aerosol Med Pulm Drug Deliv; 2010 Dec; 23(6):381-8. PubMed ID: 20958143 [TBL] [Abstract][Full Text] [Related]
15. Montelukast or salmeterol combined with an inhaled steroid in adult asthma: design and rationale of a randomized, double-blind comparative study (the IMPACT Investigation of Montelukast as a Partner Agent for Complementary Therapy-trial). Bjermer L; Bisgaard H; Bousquet J; Fabbri LM; Greening A; Haahtela T; Holgate ST; Picado C; Leff JA Respir Med; 2000 Jun; 94(6):612-21. PubMed ID: 10921768 [TBL] [Abstract][Full Text] [Related]
16. Effects of 24 weeks of lansoprazole therapy on asthma symptoms, exacerbations, quality of life, and pulmonary function in adult asthmatic patients with acid reflux symptoms. Littner MR; Leung FW; Ballard ED; Huang B; Samra NK; Chest; 2005 Sep; 128(3):1128-35. PubMed ID: 16162697 [TBL] [Abstract][Full Text] [Related]